GTDC1 expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 2.322300E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
2.435700E-02
Normal-vs-Stage2
2.753900E-02
Normal-vs-Stage3
1.553790E-01
Normal-vs-Stage4
8.692100E-02
Stage1-vs-Stage2
4.356600E-01
Stage1-vs-Stage3
6.140800E-01
Stage1-vs-Stage4
4.825000E-01
Stage2-vs-Stage3
9.388000E-01
Stage2-vs-Stage4
9.791400E-01
Stage3-vs-Stage4
9.672600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
2.283800E-02
Normal-vs-AfricanAmerican
1.069440E-01
Normal-vs-Asian
3.760100E-02
Caucasian-vs-AfricanAmerican
6.301400E-01
Caucasian-vs-Asian
3.952600E-01
AfricanAmerican-vs-Asian
3.639000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
2.653600E-02
Normal-vs-Female
2.537600E-02
Male-vs-Female
3.518400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
6.512100E-02
Normal-vs-Age(41-60Yrs)
3.773800E-02
Normal-vs-Age(61-80Yrs)
2.635600E-02
Normal-vs-Age(81-100Yrs)
2.164400E-02
Age(21-40Yrs)-vs-Age(41-60Yrs)
1.514370E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
4.482400E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
2.941600E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
8.859600E-02
Age(41-60Yrs)-vs-Age(81-100Yrs)
4.163600E-01
Age(61-80Yrs)-vs-Age(81-100Yrs)
8.485400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
1.468130E-02
Normal-vs-Daily Drinker
5.089600E-02
Normal-vs-Weekly Drinker
1.032200E-02
Normal-vs-Occasional Drinker
1.348240E-01
Normal-vs-Social Drinker
6.537500E-02
Non Drinker-vs-Daily Drinker
7.657600E-01
Non Drinker-vs-Weekly Drinker
9.094000E-01
Non Drinker-vs-Occasional Drinker
2.209000E-01
Non Drinker-vs-Social Drinker
7.671400E-01
Daily Drinker-vs-Weekly Drinker
7.283800E-01
Daily Drinker-vs-Occasional Drinker
4.154800E-01
Daily Drinker-vs-Social Drinker
9.806600E-01
Weekly Drinker-vs-Occasional Drinker
2.559000E-01
Weekly Drinker-vs-Social Drinker
7.250400E-01
Occasional Drinker-vs-Social Drinker
4.772400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
6.897600E-01
Normal-vs-Grade 2
9.816300E-02
Normal-vs-Grade 3
1.712040E-01
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
7.96320000000517E-05
Grade 1-vs-Grade 3
4.303500E-03
Grade 1-vs-Grade 4
6.897600E-01
Grade 2-vs-Grade 3
4.229400E-01
Grade 2-vs-Grade 4
9.816300E-02
Grade 3-vs-Grade 4
1.712040E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
3.465700E-02
Normal-vs-NonDiabetic
2.588200E-02
Diabetic-vs-NonDiabetic
9.002600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
1.755770E-02
Normal-vs-NoPancreatitis
2.438500E-02
Pancreatitis-vs-NoPancreatitis
9.026400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
1.966220E-02
Normal-vs-N1
3.011900E-02
N0-vs-N1
8.387700E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
4.122100E-02
Normal-vs-TP53-NonMutant
1.316260E-02
TP53-Mutant-vs-TP53-NonMutant
1.039650E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
